http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82aabc45e795d125021b230af767b2cb
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Paz-Ares |
| name | Luis Paz-Ares |
| given-name | Luis |
| organization-name | Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Av. de Córdoba km 5,4, 28041 Madrid, Spain Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octbure (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain; CIBERONC, Madrid, Spain; Department of Medicine, Complutense University, Madrid, Spain Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne; Martin Früh, Kantonsspital St Gallen, St Gallen, Switzerland; Scott Gettinger, Yale Cancer Center, New Haven, CT; Melissa L. Johnson, Sarah Cannon Research Institute, Nashville, TN; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; Marina C. Garassino, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Daniel Christoph, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen; Martin Reck,... 6Hospital Virgen del Rocío, Sevilla, Spain. Authors' Affiliations: 1Dana-Farber Cancer Institute, Boston, Massachusetts; 2H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; 3University Hospitals Leuven, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium; 4Ohio State University Comprehensive Cancer Center, Columbus, Ohio; 5Erasmus University Medical Centre, Rotterdam, The Netherlands; 6Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 7Duke University Medical Center, Durham, North Carolina; 8Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 9Institut Gustave-Roussy, Villejuif, France; 10UNSW Prince of Wales Clinical School, Randwick, Australia; 11Instituto de Biomedicina de Sevilla (IBIS), Seville and Hospital Universitario Doce de Octubre, Madrid, Spain; 12University Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France; 13Peter MacCallum Cancer Centre, Melbourne, Australia; 14Columbia University, New York, New York; 15Pfizer Oncology, La Jolla, California; and 16Istituto Nazionale Tumori, Mil Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain Hospital Universitario 12 de Octubre, H120H120-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & Ciberonc, Madrid, Spain. Instituto de Biomedicina de Sevilla (IBIS) (HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; CIBER de Cáncer, Madrid, Spain Hospital Universitario 12 de Octubre, Madrid, Spain; H120-CNIO Lung Cancer Unit, Madrid, Spain; Universidad Complutense de Madrid and Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain From the Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; University of Colorado Denver, Aurora, CO; Medical Oncology Department, Instituto de Biomedicina de Sevilla and Hospital Universitario Virgen del Rocío, Seville, Spain. IBIS (University Hospital Virgen del Rocío, Seville University and CSIC), Seville & Doce de Octubre University Hospital, Madrid, Spain Medical Oncology Service, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Medical Oncology Department, Hospital Universitario 12 de Octubre. Madrid, Spain; Lung Cancer Group, Clinical Research Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Universidad Complutense de Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Instituto de Investigación Hospital Doce de Octubre (imas12), Avenida de Córdoba s/n, 28041 Madrid, Spain; Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Ciberonc, Madrid, Spain; Departamento de Medicina, Universidad Complutense de Madrid, Avda. Complutense s/n, 28040 Madrid, Spain From the National Cancer Institute of Canada–Clinical Trials Group, Kingston; University Health Network/Princess Margaret Hospital, Toronto; The Margaret & Charles Juravinski Cancer Centre (formerly known as Hamilton Regional Cancer Centre), Hamilton, Ontario; Hospital Universitario Doce de Octubre, Madrid, Spain; Centre Rene Gauducheau, Nantes, France; Klinikum Rechts Der III Medizinische Klinik, Munich; Krankenhaus Grobhansdorf der LVA, Grobhansdorf, Germany; Hôpital Jean Minjoz, Besançon, France;... From the Hospital Universitario Doce de Octubre de Madrid, Madrid; Hospital de la Santa Creu I Sant Pau, Sant Pau; Hospital Miguel Servet de Zaragoza; Hospital Clínico Universitario de Zaragoza, Zaragoza; Hospital Clínico Universitario de Valencia, Valencia; Hospital del Mar de Barcelona, Barcelona; Hospital San Juan de Alicante; Hospital General de Alicante, Alicante; Hospital Universitario Marqués de Valdecilla de Santander, Santander; Fundación Jiménez Díaz, Madrid; Hospital Virgen del Rocío de... 5Hospital Universitario Virgen del Rocio, Seville, Spain. Laboratorio de Oncología Molecular y Nuevas Terapias, Instituto de Biomedicina de Sevilla (IBIS) (HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain; Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain Authors' Affiliations: 1Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona; 2Institute of Health Research INCLIVA, University of Valencia, Valencia; 3Hospital Virgen del Rocio, Seville, Spain; 4Dana-Farber Cancer Institute; 5Beth Israel Deaconess Medical Center, Boston; 6Alnylam Pharmaceuticals, Inc., Cambridge, Massachusetts; 7Karmanos Cancer Institute, Detroit, Michigan; 8Memorial Sloan-Kettering Cancer Center, New York, New York; 9Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona; and 10Sarah Cannon Research Institute, Nashville, Tennessee Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain; Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Mardid, Spain Medical Oncology Department, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas (CNIO), 28041 Madrid, Spain Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d’Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin... Hospital Universitario 12 de Octubre, Madrid, Spain Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Complutense University and Ciberonc, Madrid, Spain. Electronic address: lpazaresr@seom.org. H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre & Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain; Medical School, Universidad Complutense, 28040 Madrid, Spain 5Hospital Universitario 12 de Octubre, Madrid, Spain, Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain; H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Sanitaria Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Madrid, 28029, Spain; Cancer Networking Biomedical Research Center, Madrid, 28029, Spain; Faculty of Medicine, Complutense University, Madrid, 28040, Spain Massachusetts General Hospital, Harvard Medical School, Boston, MA, Copyright © 2001 American Society of Clinical Oncology Instituto de Biomedicina de Sevilla and Hospital Universitario Virgen del Rocio (L.P.-A.), 41013 Seville, Spain Hospital Universitario 12 de Octubre, CNIO, Ciberonc & Universidad Complutense, Madrid, Spain. From the Servicio de Oncología Médica, Doce de Octubre University Hospital, Madrid, Spain; Centre René Gauducheau, Saint Herblain, France; Wojewodzki Szpital Specjalistyczny, Krakow, Poland; Heidelberg University Medical Center, Mannheim, Germany; VU University Medical Center, Amsterdam, the Netherlands; Instituto de Oncología, Clínica Las Condes, Santiago, Chile; Taichung Veterans General Hospital, Taichung, Taiwan, People’s Republic of China; Commonwealth Cancer Center, Richmond, KY; Eli Lilly and Co,... From the Division of Medical Oncology, Hospital Universitario “12 de Octubre,” Madrid, Spain. Medical Oncology Department, Hospital 12 de Octubre & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain Department of Medical Oncology, Hospital Universitario 12 de Octubre , Madrid , Spain CIBER de Cáncer, Instituto de Salud Carlos III, Pabellón 11, Planta 0, Madrid, Spain; H120-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre and CNIO, Madrid, Spain Hospital Universitario Virgen del Rocío, Seville, Spain Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, CiberOnc, Madrid, Spain Department of Medical Oncology, Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense & Ciberonc, Madrid, Spain Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense & CNIO, Madrid, 28041, Spain CNIO-H12O Lung Clinical Cancer Research Unit, Fundación de Investigación Biomédica i+12 & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Medical School, Universidad Complutense, Madrid, Spain From the Memorial Sloan Kettering Cancer Center, New York (M.D.H.); Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and Centro de Investigación Biomédica en Red de Cáncer, Madrid (L.P.-A.), Hospital Universitario Virgen Del Rocio, Seville (R.B.C.), and the Catalan Institute of Oncology–Germans Trias i Pujol Hospital, Badalona (E.C.C.) — all in Spain; Ambulatorium Chemioterapii, Bydgoszcz, Poland (B.Z.); the Asan Medical Center (S.-W.K.) and... From Memorial Sloan Kettering Cancer Center Hospital, New York (M.D.H.); Prof. Dr. Ion Chiricuta Institute of Oncology and Universitatea de Medicina si Farmacie Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Centrum Onkologii–Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland (A.P.); Seoul National University Bundang Hospital, Seoul, South Korea (J.S.L.); Ohio State University, Columbus (G.A.O.); Hôpital Sainte Musse, Toulon, France (C.A.-V.); Ospedale Santa Maria della Misericordia, Perugia, Italy ... Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain Authors' Affiliations: 1Instituto de Biomedicina de Sevilla, HUVR/CSIC/Universidad de Sevilla; Departments of 2Oncology and 3Pathology, Hospital Universitario Virgen del Rocio; and 4Consejo Superior de Investigaciones Cientificas, Sevilla, Spain; Authors' Affiliations: 1Instituto de Biomedicina de Sevilla, HUVR/CSIC/Universidad de Sevilla; Departments of 2Oncology and 3Pathology, Hospital Universitario Virgen del Rocio; and 4Consejo Superior de Investigaciones Cientificas, Sevilla, Spain H120-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación 12 de Octubre and CNIO, Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre & Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Medical School, Universidad Complutense, Madrid, Spain; CiberOnc, Madrid, Spain H12O Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12), 28029 Madrid, Spain; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), 28029 Madrid, Spain; Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain; MD Anderson, 28033 Madrid, Spain Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain the Department of Oncology, 12 de Octubre University Hospital, Department of Medicine, Universidad Complutense de Madrid, Research Institute 12 de Octubre University Hospital (i+12), CIBERONC, Madrid, Spain (Paz-Ares) Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense and CIBERONC, Madrid, Spain. Laboratory of Clinical and Translational Oncology, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Av. Córdoba s/n, 28041 Madrid, Spain; Lung Cancer Group, Clinical Research Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; Biomedical Research Networking Centre on Oncology—CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain; Medical Oncology Department, Hospital Universitario 12 de Octubre, Av. Córdoba s/n, 28041 Madrid, Spain; Medicine Department, Facultad de Medicina y Cirugía, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain 9Hospital '12 de Octubize, Madrid, Spain; Instituto de Biomedicina de Sevilla - IBIS (Hospital Virgen del Rocío, Universidad de Sevilla & CSIC), Seville, Spain. H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre/Spanish National Cancer Research Center (CNIO), Madrid, Spain; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain; Medicine and Physiology Department, School of Medicine, Complutense University of Madrid, Madrid, Spain. University Hospital 12 de Octubre, Madrid, Spain; Lung Cancer Unit H12O-CNIO, Spain; Ciberonc, Spain; University Complutense de Madrid, Spain. Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain; Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain; University of Seville, Seville, Spain Medical Oncology Department, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas (CNIO), 28041 Madrid, Spain; University of Seville, Seville, Spain 7H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Sanitaria 12 de Octubre (imas12), and Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; 8Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain.; 18Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; 19Department of Medicine, Universidad Complutense, Madrid, Spain. 9Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Universidad Complutense & CiberOnc, Madrid, Spain. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Lung Cancer Clinical Research Unit and Centro Nacional de Investigaciones Oncológicas, Madrid, Spain; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain; Medical School, Universidad Complutense, Madrid, Spain H120-CNIO Lung Cancer Unit, Hospital Universitario 12 de Octubre, Universidad Complutense and Ciberonc, Madrid, Spain From Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid (L.P.-A.), and Hospital Universitario Virgen Macarena, Seville (D.V.) - both in Spain; Leningrad Regional Clinical Hospital, St. Petersburg, Russia (A.L.); Wollongong Oncology and Wollongong Private Hospital, Wollongong, NSW, Australia (A.T.); Istanbul Medeniyet University Hospital, Istanbul (M.G.), and Ankara University, Ankara (F.Ç.Ş.) - both in Turkey; Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France (J.M.); Universitätsklinikum Tübingen, Tübingen, Germany (B. Hermes); Jász-Nagykun-Szolnok County Hospital, Szolnok (T.C.), and Országos Korányi TBC és Pulmonológiai Intézet, Budapest (A.F.) - both in Hungary; Oncology Center, Medica Sur Hospital, Mexico City (J.R.-C.); Humber River Regional Hospital, Toronto (J.W.); Sendai Kousei Hospital, Sendai (S.S.), and the Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju, South Korea (K.H.L.); Jilin Cancer Hospital, Changchun, China (Y.C.); University of Turin, Orbassano, Italy (S.N.); Montefiore Medical Center-Albert Einstein College of Medicine, New York (B. Halmos); Merck, Kenilworth, NJ (X.L., G.M.L., B.P.); and the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland (D.M.K.). Molecular Oncology and New Therapies Group, Department of Medical Oncology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla, Seville, Spain Medical Oncology Department; Hospital 12 De Octubre; Madrid Spain From the Dana-Farber Cancer Institute, Boston, MA; Doce de Octubre University Hospital, Madrid; Hospital Clínico Virgen de la Victoria, Málaga, Spain; European Institute of Oncology, Milan, Italy; Universität Mainz III Med. Klinik, Mainz, Germany; University of Texas M.D. Anderson Cancer Center, Houston, TX; Universitatsklinikum of the University of Duisburg-Essen, Essen, Germany; Deenanath Mangeshkar Hospital and Research Center, Pune, India; Mary Potter Oncology Centre, Pretoria, South Africa;... From McGill University Health Centre, Montreal, Quebec, Canada; Instituto de Biomedicina de Sevilla and Hospital Universitario Virgen del Rocio, Seville; Catalan Institute of Oncology, Badalona, Spain; Sydney Cancer Centre, Camperdown, New South Wales, Australia; St Luke's Cancer Centre, Surrey, United Kingdom; West German Cancer Centre, University of Duisburg-Essen, Essen, Germany; Szpital Chrob Pluc I Gruzlicy, III, Oddzial, Otwock, Poland; Masarykova nemocnice v Usti nad Labem, Czech Republic; Georgia... David R. Spigel, Sarah Cannon Research Institute, Nashville, TN; Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Kenneth O’Byrne, Queensland University of Technology, Brisbane, Queensland, Australia; Luis Paz-Ares, Hospital Universitario Doce de Octubre and Centro Nacional de Investigaciones Oncológicas, Madrid; University of Seville, Seville, Spain; Simonetta Mocci, See Phan, David S. Shames, Dustin Smith, Wei Yu, and Virginia E. Paton, Genentech, South San Francisco,... Instituto de Biomedicina de Sevilla-IBIS (Hospital Virgen del Rocío/Universidad de Sevilla/CSIC), Sevilla, Spain; Hospital Universitario Doce de Octubre and CNIO Lung Cancer Unit, Madrid, Spain. Electronic address: lpazaresr@seom.org. 3Hospital Universitario 12 de Octubre and Medical Oncology Service, University Hospital 12 de Octubre, Madrid, Spain University Hospital 12 de Octubre, Madrid, Spain From the Hospital Carlos Haya, Malaga; Hospital Lozano Blesa, Zaragoza; Hospital General de Alicante, Alicante; Catalan Institute of Oncology, Hospital Duran i Reynals; Hospital Clinic; Hospital Vall d'Hebron, Barcelona; Hospital Alcorcon; Hospital Puerta de Hierro; Hospital Doce de Octubre; Fundacion Jimenez Diaz’ Autonomous University of Madrid, Madrid; Hospital de Cruces, Barakaldo-Bizkaia; Valencia Institute of Oncology; Hospital Arnau de Vilanova; Hospital General de Valencia, Valencia; Catalan... Department of Medical Oncology, 12 de Octubre Hospital, 28041 Madrid, Spain; Lung Cancer Clinical Research Group, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain; Ciberonc, 28029 Madrid, Spain; Medicine Department, Medicine Faculty, Complutense University, 28040 Madrid, Spain Hospital 12 de Octubre, Madrid, Spain. Joaquim Bellmunt, Vall d'Hebron University Hospital and University Hospital del Mar-Institut Municipal d'Investigació Mèdica, Barcelona; Luis Paz-Ares, Instituto de Biomedicina de Sevilla and Hospital Universitario Virgen del Rocio; University of Seville, Seville, Spain; Hans von der Maase, Aarhus University Hospital, Aarhus; Hans von der Maase and Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark; Graham M. Mead, Southampton General Hospital, Southampton, United Kingdom; Iwona Skoneczna, Maria... Medical Oncology Department, University Hospital 12 de Octubre, Complutense University, CNIO & CiberOnc, Madrid, Spain |
Incoming Links
Total number of triples: 375.